Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001062993-18-001414
Filing Date
2018-03-29
Accepted
2018-03-29 16:01:45
Documents
86
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K form10k.htm 10-K 614318
2 EXHIBIT 10.25 exhibit10-25.htm EX-10.25 38239
3 EXHIBIT 23.1 exhibit23-1.htm EX-23.1 1352
4 EXHIBIT 31.1 exhibit31-1.htm EX-31.1 5596
5 EXHIBIT 31.2 exhibit31-2.htm EX-31.2 5608
6 EXHIBIT 32.1 exhibit32-1.htm EX-32.1 2459
7 EXHIBIT 32.2 exhibit32-2.htm EX-32.2 2455
14 GRAPHIC financialsx3x1.jpg GRAPHIC 1437
15 GRAPHIC financialsx3x2.jpg GRAPHIC 1523
16 GRAPHIC exhibi1.gif GRAPHIC 847
17 GRAPHIC exhibi2.jpg GRAPHIC 8749
  Complete submission text file 0001062993-18-001414.txt   4570965

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE igxt-20171231.xml EX-101.INS 584659
9 XBRL CALCULATION FILE igxt-20171231_cal.xml EX-101.CAL 47625
10 XBRL DEFINITION FILE igxt-20171231_def.xml EX-101.DEF 376057
11 XBRL LABEL FILE igxt-20171231_lab.xml EX-101.LAB 682138
12 XBRL PRESENTATION FILE igxt-20171231_pre.xml EX-101.PRE 424879
13 XBRL SCHEMA FILE igxt-20171231.xsd EX-101.SCH 99998
Mailing Address 6420 ABRAMS SAINT LAURENT A8 H4S 1Y2
Business Address 6420 ABRAMS SAINT LAURENT A8 H4S 1Y2 514-331-7440
IntelGenx Technologies Corp. (Filer) CIK: 0001098880 (see all company filings)

EIN.: 870638336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-31187 | Film No.: 18722929
SIC: 2834 Pharmaceutical Preparations